The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin

INTRODUCTION: Between 2010 and 2012, the US Food and Drug Administration and Health Canada issued warnings to healthcare professionals emphasizing the increased risk of muscle problems with high-dose simvastatin. OBJECTIVE: To measure the impact of the Health Canada safety warning regarding dose-dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Kanika, Sketris, Ingrid, Zhang, Ying, Levy, Adrian, Gamble, John-Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684045/
https://www.ncbi.nlm.nih.gov/pubmed/28956294
http://dx.doi.org/10.1007/s40801-017-0116-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684045/
https://www.ncbi.nlm.nih.gov/pubmed/28956294
http://dx.doi.org/10.1007/s40801-017-0116-7

Ejemplares similares